Trupanion, Inc. (NASDAQ: TRUP – Get Rating) Director Michael Doak sold 700 shares of the company in a trade on Tuesday, July 5. The shares were sold at an average price of $60.00, for a total value of $42,000.00. As a result of the transaction, the administrator now directly owns 1,007 shares of the company, valued at $60,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available on the SEC’s website.
NASDAQ TRUP shares opened at $66.41 on Friday. The company’s 50-day moving average price is $62.40 and its two-hundred-day moving average price is $81.91. The company has a debt ratio of 0.16, a current ratio of 1.88 and a quick ratio of 1.88. Trupanion, Inc. has a one-year low of $50.81 and a one-year high of $158.25. The company has a market capitalization of $2.70 billion, a P/E ratio of -84.06 and a beta of 2.11.
Trupanion Inc (NASDAQ:TRUP – Get Rating) last released its quarterly results on Thursday, April 28. The financial services provider reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.05). The company posted revenue of $206.00 million for the quarter, versus a consensus estimate of $202.32 million. Trupanion had a negative return on equity of 8.66% and a negative net margin of 4.26%. The company’s revenues increased by 33.2% compared to the same quarter last year. During the same quarter last year, the company posted ($0.31) EPS. On average, stock analysts expect Trupanion, Inc. to post EPS of -0.81 for the current year.
Several research analysts have recently weighed in on TRUP shares. StockNews.com began covering Trupanion in a research report on Thursday, March 31. They put a “sell” mark on the stock. Canaccord Genuity Group lowered its price target on Trupanion from $140.00 to $100.00 in a Friday, April 29 research report. Bank of America lowered its target price on Trupanion from $118.00 to $110.00 and placed a “buy” rating on the stock in a Wednesday, April 20 research note. TheStreet downgraded Trupanion from a “c-” rating to a “d+” rating in a Wednesday, April 6 research note. Finally, Piper Sandler lowered her target price on Trupanion from $95.00 to $80.00 and set an “overweight” rating on the stock in a Friday, May 27 research note.
A number of large investors have recently changed their positions in TRUP. Aflac Inc. purchased a new stake in Trupanion during Q1 valued at approximately $324,072,000. Nine Ten Capital Management LLC increased its stake in Trupanion by 18.7% in Q1. Nine Ten Capital Management LLC now owns 2,341,919 shares of the financial services provider valued at $208,712,000 after purchasing an additional 368,343 shares during the period. Polar Capital Holdings Plc purchased a new stake in Trupanion during Q1 worth approximately $22,280,000. Capital International Investors increased its stake in Trupanion by 7.4% in the 4th quarter. Capital International Investors now owns 1,487,447 shares of the financial services provider valued at $196,388,000 after purchasing an additional 102,630 shares during the period. Finally, State Street Corp increased its stake in Trupanion by 7.6% in the 1st quarter. State Street Corp now owns 1,247,433 shares of the financial services provider valued at $111,171,000 after purchasing an additional 88,009 shares during the period. Hedge funds and other institutional investors own 83.62% of the company’s shares.
Trupanion Company Profile (Get an evaluation)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico and Australia. The Company operates in two segments, subscription business and other business. It serves pet owners and veterinarians.
Get news and reviews for Trupanion Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Trupanion and related companies with MarketBeat.com’s free daily email newsletter.